The Relationship Between Osteoporosis and Chronic Oral Anticoagulation Therapy With Warfarin

Osteoporosis Clinical Trial

Official title:

The Relationship Between Osteoporosis and Chronic Oral Anticoagulation Therapy With Warfarin

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00665613
• Other study ID #: 04-054
• Status: Completed
• Phase: N/A
• First received: April 22, 2008
• Last updated: October 13, 2015
• Start date: October 2004
• Est. completion date: March 2009

Study information

• Verified date: October 2015
• Source: Northwell Health
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to determine if osteoporosis is an unrecognized complication of chronic anticoagulation with warfarin.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 300
• Est. completion date: March 2009
• Est. primary completion date: March 2009
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years to 100 Years

Eligibility

Inclusion Criteria:

• Patients on warfarin that have had BMD within a year

Exclusion Criteria:

• Patients on bisphosphates, SERMS, anticonvulsants, estrogens, androgens, calcitonin, hctz and thyroid hormone replacement

Study Design

Observational Model: Case-Only, Time Perspective: Retrospective

Related Conditions & MeSH terms

• Osteoporosis

Locations

Country	Name	City	State
United States	Staten Island University Hospital	Staten Island	New York

Sponsors (2)

Lead Sponsor	Collaborator
Northwell Health	Staten Island University Hospital

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Bone Density	bone density as measured by xray to assess bone strength nd risk of fracture	5 to 10 years	No